Showing 1 - 5 results of 5 for search 'Xipeng Zhou', query time: 0.03s Refine Results
  1. 1
    Recent Progress on Therapeutic Vaccines for Breast Cancer

    Recent Progress on Therapeutic Vaccines for Breast Cancer by Lianru Zhang, Xipeng Zhou, Huizi Sha, Li Xie, Baorui Liu

    Published 2022-06-01
    Get full text
    Article
  2. 2
    The KP1_4563 gene is regulated by the cAMP receptor protein and controls type 3 fimbrial function in Klebsiella pneumoniae NTUH-K2044.

    The KP1_4563 gene is regulated by the cAMP receptor protein and controls type 3 fimbrial function in Klebsiella pneumoniae NTUH-K2044. by Mei Luo, Shiya Yang, Xuan Li, Pin Liu, Jian Xue, Xipeng Zhou, Kewen Su, Xuan Xu, Ying Qing, Jingfu Qiu, Yingli Li

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.

    Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis. by Xianxian Yang, Bin Tan, Xipeng Zhou, Jian Xue, Xian Zhang, Peng Wang, Chuang Shao, Yingli Li, Chaorui Li, Huiming Xia, Jingfu Qiu

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19

    Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19 by Changzhong Jin, Bin Yu, Jie Zhang, Hao Wu, Xipeng Zhou, Hangping Yao, Fumin Liu, Xiangyun Lu, Linfang Cheng, Miao Jiang, Nanping Wu

    Published 2021-04-01
    Get full text
    Article
  5. 5
    Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19

    Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19 by Changzhong Jin, Bin Yu, Jie Zhang, Hao Wu, Xipeng Zhou, Hangping Yao, Fumin Liu, Xiangyun Lu, Linfang Cheng, Miao Jiang, Nanping Wu

    Published 2021-07-01
    Get full text
    Article

Search Tools: